Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hedgehog Signaling as a Therapeutic Target for Airway Remodeling and Inflammation in Allergic Asthma.

Cells·2022
Same author

Comparative transcriptomics in human COPD reveals dysregulated genes uniquely expressed in ferrets.

Respiratory research·2022
Same author

Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive properties.

Vascular pharmacology·2022
Same author

Combination therapy with long-acting bronchodilators and the risk of major adverse cardiovascular events in patients with COPD: a systematic review and meta-analysis.

The European respiratory journal·2022
Same author

Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission.

Lancet (London, England)·2022
Same author

RETHINCking COPD - Bronchodilators for Symptomatic Tobacco-Exposed Persons with Preserved Lung Function?

The New England journal of medicine·2022
Same journal

Polyclonal free light chains: a biomarker of inflammatory disease or treatment target?

F1000 medicine reports·2013
Same journal

Advances in lens implant technology.

F1000 medicine reports·2013
Same journal

Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population.

F1000 medicine reports·2013
Same journal

Cannabis and psychosis: what causes what?

F1000 medicine reports·2013
Same journal

Prevention of atopic dermatitis.

F1000 medicine reports·2012
Same journal

Neuromodulation for treatment-resistant depression.

F1000 medicine reports·2012
See all related articles

Related Experiment Video

Updated: May 16, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

Lung inflammation in COPD: why does it matter?

Jin Young Oh1, Don D Sin

  • 1UBC James Hogg Research Center, St. Paul's Hospital Vancouver, BC, Canada ; Division of Pulmonology, Department of Internal Medicine, Dongguk University Ilsan Hospital Goyang, South Korea.

F1000 Medicine Reports
|December 14, 2012
PubMed
Summary
This summary is machine-generated.

Lung inflammation drives chronic obstructive pulmonary disease (COPD) progression. Different COPD phenotypes involve distinct molecular pathways, influencing disease development and severity.

More Related Videos

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells
09:15

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Published on: May 11, 2020

Related Experiment Videos

Last Updated: May 16, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells
09:15

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Published on: May 11, 2020

Area of Science:

  • Pulmonary Medicine
  • Inflammation Research
  • Molecular Biology

Background:

  • Chronic obstructive pulmonary disease (COPD) is marked by persistent lung inflammation.
  • Disease severity correlates with increased inflammatory responses.
  • Emerging evidence points to diverse COPD phenotypes with unique molecular underpinnings.

Purpose of the Study:

  • To synthesize the current understanding of lung inflammation's role in COPD pathogenesis.
  • To explore the distinct molecular pathways associated with different COPD phenotypes.

Main Methods:

  • Review of recent scientific literature on COPD pathogenesis.
  • Analysis of molecular mechanisms implicated in COPD phenotypes.
  • Synopsis of inflammatory processes in COPD.

Main Results:

  • Lung inflammation is a key characteristic of COPD, worsening as the disease progresses.
  • Distinct COPD phenotypes are associated with specific molecular pathways.
  • Proteolytic enzymes may drive the emphysematous phenotype.
  • Nitric oxide pathways are implicated in pulmonary vessel remodeling in COPD.

Conclusions:

  • Lung inflammation is central to the pathogenesis of COPD.
  • Understanding specific molecular pathways in COPD phenotypes is crucial for targeted therapies.
  • Further research into these pathways can elucidate COPD progression and inform treatment strategies.